Gut microbiota, inflammation and colorectal cancer
Open accessAbstract
Although genes contribute to colorectal cancer, the gut microbiota are an important player. Accumulating evidence suggests that chronic infection and the ensuing inflammation contributes to tumor initiation and tumor progression. A variety of bacterial species and tumor-promoting virulence mechanisms have been investigated. Significant advances have been made in understanding the composition and functional capabilities of the gut microbiota and its roles in cancer. In the current review, we discuss the novel roles of microbiota in the progression of colon cancer. Although microbiota technically include organisms other than bacteria e.g., viruses and fungi, this review will primarily focus on bacteria. We summarize epidemiological studies of human microbiome and colon cancer. We discuss the progress in the scientific understanding of the interplay between the gut microbiota, barrier function, and host responses in experimental models. Further, we discuss the potential application in prevention, diagnosis, and therapy of colon cancer by targeting microbiota. We discuss the challenges lie ahead and the future direction in studying gut microbiome in colon cancer to close the gap between the basic sciences and clinical application.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Strategies to detect specific bacteria or bacterial DNA sequences might be used in screening for early-stage colorectal adenomas or carcinomas.
“Strategies to detect specific bacteria or bacterial DNA sequences might be used in screening for early-stage colorectal adenomas or carcinomas.60, 61”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
Duca, F. A., Sakar, Y., Lepage, P., Devime, F., Goustard, B., Dore, J. M., & Covașă, M. (2014) · Diabetes · doi:10.2337/db13-1526 · Cited by 162 · see citing works
RetractedCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766 · see citing works
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111 · see citing works
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1× · see citing works
“While low energy diet induces change in microbial compositions increasing gene richness,(107) microbiome itself also contributes energy harvest to the host, as demonstrated in mice models where transfer of obese microbiome to lean animals led to an increase in body adiposity in a diet dependent manner.(108,109) Other…”
BackgroundDiet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1× · see citing works
“Although meat intake itself has been rarely studied, removal of animal products (vegan diet) was recently tested in a few clinical trials, showing changes in the Firmicutes/Bacteroidetes ratio and abundance of bacteria capable of triggering inflammation.(112,113) Moreover, as discussed above, meats are one of the susp…”
BackgroundDiversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913 · see citing works
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 1× · see citing works
“Obese and lean individuals are known to harbor different types of gut microbiota.(106) While low energy diet induces change in microbial compositions increasing gene richness,(107) microbiome itself also contributes energy harvest to the host, as demonstrated in mice models where transfer of obese microbiome to lean a…”
BackgroundSokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413 · see citing works
Commensal <i>Bifidobacterium</i> promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888 · see citing works
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241 · cited 2× · see citing works
“Another bacterial product Peptidoglycan (PTGN) modulates peripheral immune function via a patternrecognition receptor, oligomerization domain-containing protein-1 (NOD1) and depletion of the microbiota in mice.(133) Lower systemic PTGN concentration leads to less ability to kill certain bacterial pathogens.”
BackgroundSuerbaum, S., & Michetti, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020542 · Cited by 2,984 · see citing works
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932 · see citing works
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., & Plummer, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70137-7 · Cited by 2,540 · see citing works
The Global Burden of Nontyphoidal Salmonella Gastroenteritis
Majowicz, S. E., Musto, J., Scallan, E., Angulo, F. J., Kirk, M., O’Brien, S. J., Jones, T. F., Fazil, A., & Hoekstra, R. M. (2010) · Clinical Infectious Diseases · doi:10.1086/650733 · Cited by 2,465 · see citing works
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263 · see citing works
Round, J. L., & Mazmanian, S. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909122107 · Cited by 2,233 · cited 1× · see citing works
“Polysaccharide A, produced by a commensal bacteria, increases local interleukin 10 by inducing Foxp3þ regulatory T-cell and this effect is mediated by Toll like receptor 2 signaling.(156,157) Although recent studies provide insights into the roles of the bacterial products, the molecular mechanisms of the beneficial e…”
Background<i>Fusobacterium nucleatum</i> infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043 · cited 1× · see citing works
“These observations were further confirmed by quantitative (q) PCR and in situ hybridization in tumor tissue.(16,86,89) Using qPCR, McCoy et al studied F counts in normal rectal mucosa of the cases with or without colorectal adenoma, revealing a 3 fold increase in risk of adenoma among subjects with highest tertile of…”
MethodGenomic analysis identifies association of <i>Fusobacterium</i> with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960 · cited 2× · see citing works
“These observations were further confirmed by quantitative (q) PCR and in situ hybridization in tumor tissue.(16,86,89) Using qPCR, McCoy et al studied F counts in normal rectal mucosa of the cases with or without colorectal adenoma, revealing a 3 fold increase in risk of adenoma among subjects with highest tertile of…”
BackgroundDietary intervention impact on gut microbial gene richness
Cotillard, A., Kennedy, S. P., Kong, L. C., Prifti, E., Pons, N., Le Chatelier, E., Almeida, M., Quinquis, B., Levenez, F., Galleron, N., et al. (2013) · Nature · doi:10.1038/nature12480 · Cited by 1,832 · see citing works
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812 · cited 2× · see citing works
“BFT binds to a specific colonic epithelial receptor activating Wnt and NF-kB signaling pathways with increased cell proliferation, epithelial release of proinflammatory mediators, and induction of DNA damage(78,79) and ETBF promotes tumor formation in experimental animals.(79,80) Despite these laboratory data, to date…”
BackgroundSchwabe, R. F., & Jobin, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3610 · Cited by 1,689 · see citing works
Schistosomes, liver flukes and Helicobacter pylori.
(1994) · PubMed Central · Cited by 1,529 · see citing works
Exercise and associated dietary extremes impact on gut microbial diversity
Clarke, S. F., Murphy, E. F., O'Sullivan, O., Lucey, A. J., Humphreys, M., Hogan, A., Hayes, P., O'Reilly, M., Jeffery, I. B., Wood-Martin, R., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306541 · Cited by 1,439 · cited 1× · see citing works
“A study from Ireland found that athletes hard significantly higher microbial diversity than controls.(114) Alcoholics have been reported to carry greater abundance of Proteobacteria or its family Enterobacteriaceae(115,116) than control subjects.”
BackgroundPotential of fecal microbiota for early-stage detection of colorectal cancer
Zeller, G., Tap, J., Voigt, A. Y., Sunagawa, S., Kultima, J. R., Costea, P. I., Amiot, A., Böhm, J., Brunetti, F., Habermann, N., et al. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145645 · Cited by 1,375 · see citing works
Adenoma–linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Grivennikov, S. I., Wang, K., Mucida, D., Stewart, C. A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.-Y., Österreicher, C. H., Hung, K. E., et al. (2012) · Nature · doi:10.1038/nature11465 · Cited by 1,327 · see citing works
Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers
Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X., Jia, W., Cai, S., & Zhao, L. (2012) · The ISME Journal · doi:10.1038/ismej.2011.109 · Cited by 1,287 · cited 1× · see citing works
“Others did not find differences in these alpha diversity indices.(9,10,15,16) With or without using additional quantitative PCR (qPCR), these studies have also found that specific bacterial groups were more common or less common in colorectal cancer cases than control specimens.”
BackgroundAlleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Wallace, B. D., Wang, H., Lane, K. T., Scott, J. E., Orans, J., Koo, J. S., Venkatesh, M., Jobin, C., Yeh, L.-A., Mani, S., et al. (2010) · Science · doi:10.1126/science.1191175 · Cited by 1,080 · see citing works
Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives
Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., Vandamme, P., & Vermeire, S. (2011) · Gut · doi:10.1136/gut.2010.223263 · Cited by 1,063 · cited 2× · see citing works
“However, there have been only sporadic studies reporting a significant association with colorectal cancer itself,(101,102) while others found higher prevalence or density of these bacteria in IBD than in controls, which was further correlated with disease activity.(4,103,104) In addition to F.”
BackgroundResultHuman Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer
Chen, W., Liu, F., Ling, Z., Tong, X., & Xiang, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039743 · Cited by 1,029 · see citing works
Fat, fibre and cancer risk in African Americans and rural Africans
O’Keefe, S. J. D., Li, J. V., Lahti, L., Ou, J., Carbonero, F., Mohammed, K., Posma, J. M., Kinross, J., Wahl, E., Ruder, E., et al. (2015) · Nature Communications · doi:10.1038/ncomms7342 · Cited by 982 · see citing works
Human Gut Microbiome and Risk for Colorectal Cancer
Ahn, J., Sinha, R., Pei, Z., Dominianni, C., Wu, J., Shi, J., Goedert, J. J., Hayes, R. B., & Yang, L. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt300 · Cited by 947 · cited 1× · see citing works
“The potential association of this bacterium with colorectal cancer may be further corroborated by several other metagenomic studies that observed the overrepresentation of genus Porphyromonas or Porphyromonadaceae family in colorectal cancer specimens than control specimens.(10,13,92) Overall, the information availabl…”
ResultA bacterial driver–passenger model for colorectal cancer: beyond the usual suspects
Tjalsma, H., Boleij, A., Marchesi, J. R., & Dutilh, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2819 · Cited by 903 · cited 1× · see citing works
“Cancer incidence in the large intestine is also known to be approximately 12-fold higher than that of the small intestine, which has been attributed to several magnitude greater bacterial density in the large intestine (w10(12) cells per ml) compared with that in the small intestine (w10(2) cells per ml).(3) With adva…”
BackgroundCorrelation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota
Albenberg, L., Esipova, T. V., Judge, C. P., Bittinger, K., Chen, J., Laughlin, A., Grunberg, S., Baldassano, R. N., Lewis, J. D., Li, H., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.020 · Cited by 886 · cited 1× · see citing works
“But it is now clear that bacterial populations in feces and mucosa are distinct.(6,7) As summarized in Table 1, the majority of these studies have demonstrated beta diversity by principal coordinate or component analysis illustrating structural difference of gut microbiome, where samples belonging to different disease…”
BackgroundFusobacterium nucleatum: a commensal-turned pathogen
Han, Y. W. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2014.11.013 · Cited by 832 · cited 1× · see citing works
“nucleatum is perhaps best appreciated for its role as a component of oral plaque, where by virtue of its adhesive abilities it serves as a bridge organism between early and late colonizers of this biofilm and consequently is implicated in various forms of periodontal diseases.(84) Until recently, F.”
BackgroundMicrobial Dysbiosis in Colorectal Cancer (CRC) Patients
Sobhani, I., Tap, J., Roudot‐Thoraval, F., Roperch, J. P., Letulle, S., Langella, P., Corthier, G., Nhieu, J. T. V., & Furet, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016393 · Cited by 832 · see citing works
Colonic microbiome is altered in alcoholism
Mutlu, E. A., Gillevet, P. M., Rangwala, H., Sikaroodi, M., Naqvi, A., Engen, P. A., Kwasny, M., Lau, C. K., & Keshavarzian, A. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00380.2011 · Cited by 775 · see citing works
Martin, H., Campbell, B. J., Hart, C. A., Mpofu, C., Nayar, M. K., Singh, R., Englyst, H. N., Williams, H. F., & Rhodes, J. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.054 · Cited by 719 · see citing works
Microbiota organization is a distinct feature of proximal colorectal cancers
Dejea, C. M., Wick, E. C., Hechenbleikner, E. M., White, J. R., Mark Welch, J. L., Rossetti, B. J., Peterson, S. N., Snesrud, E. C., Borisy, G. G., Lazarev, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406199111 · Cited by 700 · see citing works
Tlaskalová-Hogenová, H., Štěpánková, R., Kozáková, H., Hudcovic, T., Vannucci, L., Tučková, L., Rossmann, P., Hrnčíř, T., Kverka, M., Zákostelská, Z., et al. (2011) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.67 · Cited by 693 · cited 1× · see citing works
“, probiotics and prebiotics) whose administration may aid in disease prevention and treatment.(122)”
BackgroundMantovani, A. (2008) · Nature · doi:10.1038/457036b · Cited by 646 · cited 2× · see citing works
“Accumulating evidence suggests that chronic infection and the ensuing inflammation contributes to tumor initiation and tumor progression.(137,154) A variety of bacterial species and tumorpromoting virulence mechanisms have been investigated, using mouse models.”
BackgroundStool microbiome and metabolome differences between colorectal cancer patients and healthy adults
Weir, T. L., Manter, D. K., Sheflin, A. M., Barnett, B. A., Heuberger, A. L., & Ryan, E. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070803 · Cited by 642 · cited 1× · see citing works
“Others did not find differences in these alpha diversity indices.(9,10,15,16) With or without using additional quantitative PCR (qPCR), these studies have also found that specific bacterial groups were more common or less common in colorectal cancer cases than control specimens.”
BackgroundThe Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625 · see citing works
Goodwin, A. C., Shields, C. E. D., Wu, S., Huso, D. L., Wu, X., Murray-Stewart, T. R., Hacker-Prietz, A., Rabizadeh, S., Woster, P. M., Sears, C. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010203108 · Cited by 612 · cited 1× · see citing works
“BFT binds to a specific colonic epithelial receptor activating Wnt and NF-kB signaling pathways with increased cell proliferation, epithelial release of proinflammatory mediators, and induction of DNA damage(78,79) and ETBF promotes tumor formation in experimental animals.(79,80) Despite these laboratory data, to date…”
BackgroundTowards the Human Colorectal Cancer Microbiome
Marchesi, J. R., Dutilh, B. E., Hall, N., Peters, W. H. M., Roelofs, R., Boleij, A., & Tjalsma, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020447 · Cited by 552 · cited 2× · see citing works
“, imbalance in of normal intestinal microbiota, can promote chronic inflammatory conditions and the production of carcinogenic metabolites, leading to neoplasia.(4,5) Gut microbiota represents a complex ecosystem that develops in close parallel with hosts and depends on the physiological environment of hosts.”
BackgroundThe human gut microbiome as a screening tool for colorectal cancer
Zackular, J. P., Rogers, M. A. M., Ruffin, M. T., & Schloss, P. D. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0129 · Cited by 551 · cited 1× · see citing works
“The potential association of this bacterium with colorectal cancer may be further corroborated by several other metagenomic studies that observed the overrepresentation of genus Porphyromonas or Porphyromonadaceae family in colorectal cancer specimens than control specimens.(10,13,92) Overall, the information availabl…”
ResultHigh Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer
Buc, E., Dubois, D., Sauvanet, P., Raisch, J., Delmas, J., Darfeuille-Michaud, A., Pezet, D., & Bonnet, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056964 · Cited by 535 · cited 2× · see citing works
“coli positive to the pks island or genes in the island has been recently found more common in the mucosa of colorectal cancer and IBD patients than that of control subjects.(71,75,76) Epithelial proliferation and E.”
BackgroundAssociation of<i>Streptococcus bovis</i>with Carcinoma of the Colon
Klein, R. S., Recco, R. A., Catalano, M. T., Edberg, S. C., Casey, J. I., & Steigbigel, N. H. (1977) · New England Journal of Medicine · doi:10.1056/nejm197710132971503 · Cited by 532 · see citing works
Fusobacterium Is Associated with Colorectal Adenomas
McCoy, A. N., Araújo-Pérez, F., Azcárate-Peril, M. A., Yeh, J. J., Sandler, R. S., & Keku, T. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053653 · Cited by 516 · cited 1× · see citing works
“Using qPCR, McCoy et al studied F counts in normal rectal mucosa of the cases with or without colorectal adenoma, revealing a 3 fold increase in risk of adenoma among subjects with highest tertile of F counts.(90) Ito et al(91) also demonstrated that F.”
BackgroundIntestinal floras of populations that have a high risk of colon cancer
Moore, W. E., & Moore, L. H. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.9.3202-3207.1995 · Cited by 488 · cited 1× · see citing works
“Using culture methods, Moore and Moore observed that the abundance of Bacteroides and bifidobacteria was associated with increased risk of colon polyps, whereas Lactobacillus and Eubacterium aerofaciens were protective.(135) An association between the abundance of Fusobacterium, E.”
MethodZhao, M. D., Yang, M., Li, X., Jiang, P., Baranov, E., Li, S., Xu, M., Penman, S., & Hoffman, R. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408422102 · Cited by 488 · cited 1× · see citing works
“In animal models, Salmonella and its derivatives have been observed invading transformed tissue more efficiently than normal tissue.(141,142) Salmonella AvrA is a multifunctional protein that influences eukaryotic cell pathways by altering ubiquitination and acetylation of target proteins.”
BackgroundCougnoux, A., Dalmasso, G., Martinez, R., Buc, E., Delmas, J., Gibold, L., Sauvanet, P., Darcha, C., Déchelotte, P., Bonnet, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305257 · Cited by 486 · see citing works
Colonization of the Human Gut by <i>E. coli</i> and Colorectal Cancer Risk
Bonnet, M., Buc, E., Sauvanet, P., Darcha, C., Dubois, D., Pereira, B., Déchelotte, P., Bonnet, R., Pezet, D., & Darfeuille-Michaud, A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1343 · Cited by 475 · cited 1× · see citing works
“coli positive to the pks island or genes in the island has been recently found more common in the mucosa of colorectal cancer and IBD patients than that of control subjects.(71,75,76) Epithelial proliferation and E.”
BackgroundGut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells
Belcheva, A., Irrazabal, T., Robertson, S. J., Streutker, C., Maughan, H., Rubino, S., Moriyama, E. H., Copeland, J. K., Surendra, A., Kumar, S., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.051 · Cited by 473 · see citing works
<i>Fusobacterium</i> in Colonic Flora and Molecular Features of Colorectal Carcinoma
Tahara, T., Yamamoto, E., Suzuki, H., Maruyama, R., Chung, W., Garriga, J., Jelinek, J., Yamano, H.-O., Sugai, T., An, B., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1865 · Cited by 465 · cited 1× · see citing works
“These observations were further confirmed by quantitative (q) PCR and in situ hybridization in tumor tissue.(16,86,89) Using qPCR, McCoy et al studied F counts in normal rectal mucosa of the cases with or without colorectal adenoma, revealing a 3 fold increase in risk of adenoma among subjects with highest tertile of…”
MethodA possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer
Ulger Toprak, N., Yagci, A., Gulluoglu, B. M., Akin, M. L., Demirkalem, P., Celenk, T., & Soyletir, G. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01494.x · Cited by 454 · see citing works
Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients
Wu, N., Yang, X., Zhang, R., Li, J., Xiao, X., Hu, Y., Chen, Y., Yang, F., Lu, N., Wang, Z., et al. (2013) · Microbial Ecology · doi:10.1007/s00248-013-0245-9 · Cited by 454 · cited 2× · see citing works
“The potential association of this bacterium with colorectal cancer may be further corroborated by several other metagenomic studies that observed the overrepresentation of genus Porphyromonas or Porphyromonadaceae family in colorectal cancer specimens than control specimens.(10,13,92) Overall, the information availabl…”
BackgroundResultGradel, K. O., Nielsen, H. L., Schønheyder, H. C., Ejlertsen, T., Kristensen, B., & Nielsen, H. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.001 · Cited by 424 · cited 1× · see citing works
“These chronic infections increase the risk of several gastrointestinal(138) diseases, including chronic cholecystitis and gallbladder cancer.(139,140) Recently, Kato et al reported that antibody against Salmonella flagellin was higher in colorectal cancer and pre-cancer cases than controls in two distinct populations…”
BackgroundEnterotoxigenic Bacteroides fragilis : a Rogue among Symbiotes
Sears, C. L. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00053-08 · Cited by 412 · cited 2× · see citing works
“fragilis.(78) BFT binds to a specific colonic epithelial receptor activating Wnt and NF-kB signaling pathways with increased cell proliferation, epithelial release of proinflammatory mediators, and induction of DNA damage(78,79) and ETBF promotes tumor formation in experimental animals.”
BackgroundSmoking Cessation Induces Profound Changes in the Composition of the Intestinal Microbiota in Humans
Biedermann, L., Zeitz, J., Mwinyi, J., Sutter-Minder, E., Rehman, A., Ott, S. J., Steurer-Stey, C. A., Frei, A. L., Frei, P., Scharl, M. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059260 · Cited by 411 · see citing works
Gastric precancerous process in a high risk population: cohort follow-up.
Correa, P., Haenszel, W. M., Cuello, C., Zavala, D., Fontham, E., Zarama, G., Tannenbaum, S. R., Collazos, T., & Ruiz, B. (1990) · PubMed · Cited by 375 · see citing works
Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?
Kavanagh, D. O., Chambers, G., Grady, L. O., Barry, K. M., Waldron, R. P., Bennani, F., Eustace, P. W., & Tobbia, I. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-1 · Cited by 367 · see citing works
Suzuki, T., Yoshida, S., & Hara, H. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508888733 · Cited by 356 · see citing works
Co-occurrence of anaerobic bacteria in colorectal carcinomas
Warren, R. L., Freeman, D. J., Pleasance, S., Watson, P., Moore, R. A., Cochrane, K., Allen-Vercoe, E., & Holt, R. A. (2013) · Microbiome · doi:10.1186/2049-2618-1-16 · Cited by 348 · see citing works
Ahn, J., Segers, S., & Hayes, R. B. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs112 · Cited by 342 · see citing works
Picco, M. F. (2010) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(09)79399-7 · Cited by 316 · see citing works
Ramadass, B., Rajendiran, E., George, S., Samuel, G. V., & Ramakrishna, B. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05490.x · Cited by 307 · cited 1× · see citing works
“These include Desulfovibrio, Enterococcus faecalis due to hydrogen sulfide and superoxide respectively,(100) Faecalibacterium prausnitzii and Bifidobacteria due to butyrate and lactate, respectively.(101,102) The presence or density/quantity of these bacteria in feces or mucosa has been primarily studied by qPCR.”
BackgroundAssociation between intraepithelial Escherichia coli and colorectal cancer
Swidsinski, A. V., Khilkin, M., Kerjaschki, D., Schreiber, S., Ortner, M., Weber, J., & Lochs, H. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70194-5 · Cited by 302 · see citing works
Ito, M., Kanno, S., Nosho, K., Sukawa, Y., Mitsuhashi, K., Kurihara, H., Igarashi, H., Takahashi, T., Tachibana, M., Takahashi, H., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29488 · Cited by 288 · see citing works
Collier-Hyams, L. S., Zeng, H., Sun, J., Tomlinson, A. D., Bao, Z., Chen, H., Madara, J., Orth, K., & Neish, A. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.2846 · Cited by 276 · see citing works
Gastrin and colorectal cancer: A prospective study
Thorburn*, C. M., Friedman‡, G. D., Dickinson§, C. J., Vogelman∥, J. H., Orentreich∥, N., & Parsonnet*, #. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70193-3 · Cited by 267 · see citing works
Mira‐Pascual, L., Cabrera‐Rubio, R., Ocon, S. M., Costales, P., Parra, A., Suárez, A., Morís, F., Rodrigo, L., Mira, Á., & Collado, M. C. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0963-x · Cited by 260 · cited 1× · see citing works
“But it is now clear that bacterial populations in feces and mucosa are distinct.(6,7) As summarized in Table 1, the majority of these studies have demonstrated beta diversity by principal coordinate or component analysis illustrating structural difference of gut microbiome, where samples belonging to different disease…”
BackgroundCoordination of tolerogenic immune responses by the commensal microbiota
Round, J. L., O’Connell, R. M., & Mazmanian, S. K. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.007 · Cited by 260 · cited 1× · see citing works
“Polysaccharide A, produced by a commensal bacteria, increases local interleukin 10 by inducing Foxp3þ regulatory T-cell and this effect is mediated by Toll like receptor 2 signaling.(156,157) Although recent studies provide insights into the roles of the bacterial products, the molecular mechanisms of the beneficial e…”
BackgroundCommensal Bacteria, Redox Stress, and Colorectal Cancer: Mechanisms and Models
Huycke, M. M., & Gaskins, H. R. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422900702 · Cited by 244 · see citing works
Hu, S., Dong, T. S., Dalal, S. R., Wu, F., Bissonnette, M., Kwon, J. H., & Chang, E. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016221 · Cited by 231 · see citing works
Over-expression of COX-2 mRNA in colorectal cancer
Roelofs, H. M. J., Morsche, R. H. T., van Heumen, B. W. H., Nagengast, F. M., & Peters, W. H. M. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-1 · Cited by 225 · see citing works
Damman, C. J., Miller, S. I., Surawicz, C. M., & Zisman, T. L. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.93 · Cited by 224 · cited 2× · see citing works
“Bacterial metabolic products Firmicutes and Bacteroidetes predominate the gut microbiota, followed by Proteobacteria and Actinobacteria, with minor contributors including Verrucomicrobia and Fusobacteria.123 Bacteroides and Ruminococcus are consistent with enriched intake of animal sources, while a plant-based diet fa…”
BackgroundKim, M., Hwang, S., Park, E., & Bae, J. (2013) · Environmental Microbiology Reports · doi:10.1111/1758-2229.12079 · Cited by 220 · cited 1× · see citing works
“Although meat intake itself has been rarely studied, removal of animal products (vegan diet) was recently tested in a few clinical trials, showing changes in the Firmicutes/Bacteroidetes ratio and abundance of bacteria capable of triggering inflammation.(112,113) Moreover, as discussed above, meats are one of the susp…”
BackgroundStreptococcus bovis Septicemia and Carcinoma of the Colon
Klein, R. S., CATALANO, M. T., EDBERG, S. C., CASEY, J. I., & STEIGBIGEL, N. H. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-4-560 · Cited by 214 · see citing works
Salmonella Effector AvrA Regulation of Colonic Epithelial Cell Inflammation by Deubiquitination
Ye, Z., Petrof, E. O., Boone, D. L., Claud, E. C., & Sun, J. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070220 · Cited by 212 · see citing works
Hardt, W., & Galán, J. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9887 · Cited by 212 · see citing works
Microbiome, demystifying the role of microbial communities in the biosphere
Wommack, K. E., & Ravel, J. (2013) · Microbiome · doi:10.1186/2049-2618-1-1 · Cited by 209 · see citing works
Lu, R., Wu, S., Zhang, Y.-G., Xia, Y., Liu, X., Zheng, Y., Chen, H., Schaefer, K. L., Zhou, Z., Bissonnette, M., et al. (2014) · Oncogenesis · doi:10.1038/oncsis.2014.20 · Cited by 206 · cited 2× · see citing works
“Uninfected mice treated with AOM/DSS developed tumors in the distal colon.(150) In contrast, in mice infected with AvrAexpressing bacteria, tumors were found more in the proximal colon.”
BackgroundSelf-citationThe gastrointestinal microbiota and colorectal cancer
Keku, T. O., Dulal, S., Deveaux, A. E., Jovov, B., & Han, X. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00360.2012 · Cited by 205 · cited 1× · see citing works
“Transplanting feces from mice with CRC into germ-free mice leads to increased tumorigenesis.(153) While emerging evidence suggests a link between the gut microbiota and colon cancer, it is hard to say that certain bacteria strain(s) play a causal role in CRC.”
BackgroundAssociation of Streptococcus bovis Bacteremia With Colonic Neoplasia and Extracolonic Malignancy
Gold, J. S. (2004) · Archives of Surgery · doi:10.1001/archsurg.139.7.760 · Cited by 202 · see citing works
Fite, A., Macfarlane, G. T., Cummings, J. H., Hopkins, M. J., Kong, S. C., Furrie, E., & Macfarlane, S. (2004) · Gut · doi:10.1136/gut.2003.031245 · Cited by 199 · cited 1× · see citing works
“However, there have been only sporadic studies reporting a significant association with colorectal cancer itself,(101,102) while others found higher prevalence or density of these bacteria in IBD than in controls, which was further correlated with disease activity.(4,103,104) In addition to F.”
ResultRuoff, K. L., Miller, S. I., Garner, C., Ferraro, M. J., & Calderwood, S. B. (1989) · Journal of Clinical Microbiology · doi:10.1128/jcm.27.2.305-308.1989 · Cited by 197 · see citing works
Role of colonic microbiota in colorectal carcinogenesis: A systematic review
Borges‐Canha, M. (2015) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2015.3830/2015 · Cited by 192 · cited 1× · see citing works
“It is clear that bacteria metabolites amino acids are increased and butyrate is decreased throughout colonic carcinogenesis.(121) Identification of components of the microbiota and elucidation of the molecular mechanisms of their action in inducing pathological changes or exerting beneficial activities could aid in ou…”
BackgroundDisease tolerance mediated by microbiome <i>E. coli</i> involves inflammasome and IGF-1 signaling
Schieber, A. M. P., Lee, Y. M., Chang, M. W., Leblanc, M., Collins, B., Downes, M., Evans, R. M., & Ayres, J. S. (2015) · Science · doi:10.1126/science.aac6468 · Cited by 189 · cited 2× · see citing works
“This effect was dependent on engagement of the NLRC4 inflammasome.(161) Therefore, commensal bacteria in gut promote tolerance to diverse diseases.”
BackgroundShort- and Long-term Effects of Bacterial Gastrointestinal Infections
Ternhag, A., Törner, A., Svensson, Å., Ekdahl, K., & Giesecke, J. (2008) · Emerging infectious diseases · doi:10.3201/eid1401.070524 · Cited by 185 · cited 1× · see citing works
“Two studies from Scandinavian countries have found that the probability of new IBD diagnosis significantly (2e3 fold) increases compared with general population following an episode of non-typhoid salmonella infection, particularly within the first 10 years.(97,98) Although data directly linking to colorectal cancer a…”
BackgroundBiedermann, L., Brülisauer, K., Zeitz, J., Frei, P., Scharl, M., Vavricka, S. R., Fried, M., Loessner, M. J., Rogler, G., & Schuppler, M. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000129 · Cited by 178 · see citing works
Human gut microbiota: Does diet matter?
Maukonen, J., & Saarela, M. (2015) · Proceedings of The Nutrition Society · doi:10.1017/s0029665114000688 · Cited by 177 · cited 1× · see citing works
“Dietary fiber and resistant starch are well known to stimulate gut bacterial fermentation to generate short chain fatty acids (SCFA) as well as lactate and to increase relative abundance of bacterial groups with the relevant metabolic activities.(111) Although meat intake itself has been rarely studied, removal of ani…”
BackgroundNagaraja, V., & Eslick, G. D. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12655 · Cited by 161 · cited 1× · see citing works
“Salmonellosis has also been implicated in the development of various chronic sequelae, including reactive arthritis, irritable bowel syndrome, IBD(95) and even cancer.(96) Two studies from Scandinavian countries have found that the probability of new IBD diagnosis significantly (2e3 fold) increases compared with gener…”
BackgroundSalmonellosis and the gastrointestinal tract: More than just peanut butter
Crum-Cianflone, N. F. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0079-7 · Cited by 157 · see citing works
Burnett‐Hartman, A. N., Newcomb, P. A., & Potter, J. D. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0571 · Cited by 157 · cited 1× · see citing works
“In addition, there may be indirect consequences from gastric pathology, such as hypergastrinemia, which is common in patients with Helicobacter infection and has been hypothesized to stimulate colorectal tumor growth.(70)”
BackgroundEnteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease
Jess, T., Simonsen, J., Nielsen, N. M., Jørgensen, K. T., Bager, P., Ethelberg, S., & Frisch, M. (2010) · Gut · doi:10.1136/gut.2010.223396 · Cited by 154 · cited 1× · see citing works
“Two studies from Scandinavian countries have found that the probability of new IBD diagnosis significantly (2e3 fold) increases compared with general population following an episode of non-typhoid salmonella infection, particularly within the first 10 years.(97,98) Although data directly linking to colorectal cancer a…”
BackgroundEndocarditis due to group D streptococci
Moellering, R. C., Watson, B. K., & Kunz, L. J. (1974) · The American Journal of Medicine · doi:10.1016/0002-9343(74)90448-3 · Cited by 153 · see citing works
Helicobacter pylori infection in gastric cancerogenesis.
Konturek, P. C., Konturek, S. J., & Brzozowski, T. (2009) · PubMed · Cited by 151 · see citing works
Maddocks, O. D. K., Short, A., Donnenberg, M. S., Bader, S. A., & Harrison, D. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005517 · Cited by 150 · see citing works
Rosignoli, P. (2001) · Carcinogenesis · doi:10.1093/carcin/22.10.1675 · Cited by 147 · cited 1× · see citing works
“SCFA promotes and maintains colonic epithelial health through maintaining barrier function,(129) suppressing colonic cancer, inhibiting intestinal inflammation (Wu et al 2014), modulating immune response,(133) regulating DNA methylation for proliferation,(132) and diminishing oxidative DNA damage.(134) The balance bet…”
BackgroundAllen‐Vercoe, E., Strauss, J., & Chadee, K. (2011) · Gut Microbes · doi:10.4161/gmic.2.5.18603 · Cited by 145 · see citing works
Streptococcus bovis endocarditis, a silent sign for colonic tumour
Gupta, A., Madani, R., & Mukhtar, H. (2009) · Colorectal Disease · doi:10.1111/j.1463-1318.2009.01814.x · Cited by 143 · see citing works
Tuomisto, S., Pessi, T., Collin, P., Vuento, R., Aittoniemi, J., & Karhunen, P. J. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-40 · Cited by 141 · see citing works
Streptococcus bovis Bacteremia and Underlying Gastrointestinal Disease
Murray, H. W. (1978) · Archives of Internal Medicine · doi:10.1001/archinte.1978.03630320037013 · Cited by 140 · see citing works
Bindels, L. B., Neyrinck, A. M., Salazar, N., Taminiau, B., Druart, C., Muccioli, G. G., François, E., Blecker, C. S., Richel, A., Daube, G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131009 · Cited by 136 · see citing works
Shazali, N., Foo, H. L., Loh, T. C., Choe, D. W., & Rahim, R. A. (2014) · Gut Pathogens · doi:10.1186/1757-4749-6-1 · Cited by 133 · see citing works
Fusobacterium and Enterobacteriaceae: Important players for CRC?
Allen‐Vercoe, E., & Jobin, C. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.05.014 · Cited by 132 · see citing works
The Triad of Streptococcus Bovis Bacteremia, Colonic Pathology, and Liver Disease
Zarkin, B. A., Lillemoe, K. D., Cameron, J. L., Effron, P. N., Magnuson, T. H., & Pitt, H. A. (1990) · Annals of Surgery · doi:10.1097/00000658-199006000-00019 · Cited by 132 · see citing works
Salmonella regulation of intestinal stem cells through the Wnt/β‐catenin pathway
Liu, X., Lu, R., Wu, S., & Sun, J. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.024 · Cited by 130 · see citing works
Randazzo, C. L., Vaughan, E. E., & Caggia, C. (2006) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2005.11.002 · Cited by 127 · see citing works
Diversified pattern of the human colorectal cancer microbiome
Geng, J., Fan, H., Tang, X., Zhai, H., & Zhang, Z. (2013) · Gut Pathogens · doi:10.1186/1757-4749-5-2 · Cited by 126 · cited 1× · see citing works
“On the contrary a richness index was higher in rectal mucosa of colorectal cancer patients than in that of control subjects(7) or in cancer tissues than paired normal tissue.(11) Others did not find differences in these alpha diversity indices.”
BackgroundScanlan, P. D., Shanahan, F., & Marchesi, J. R. (2009) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2009.00709.x · Cited by 124 · cited 1× · see citing works
“coli, hydrogen sulfide (H2S)-, and bile salt-producing bacteria was associated with increased risk of colon cancer.(5,136) Cancer is associated with reduced abundances of Clostridium, Roseburia, Eubacteria spp.”
BackgroundGueimonde, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i29.3985 · Cited by 124 · cited 1× · see citing works
“These include Desulfovibrio, Enterococcus faecalis due to hydrogen sulfide and superoxide respectively,(100) Faecalibacterium prausnitzii and Bifidobacteria due to butyrate and lactate, respectively.(101,102) The presence or density/quantity of these bacteria in feces or mucosa has been primarily studied by qPCR.”
BackgroundBeck, M., Frodl, R., & Funke, G. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00078-08 · Cited by 122 · see citing works
Liao, A. P., Petrof, E. O., Kuppireddi, S., Zhao, Y., Xia, Y., Claud, E. C., & Sun, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002369 · Cited by 121 · see citing works
Infection as a risk factor for gallbladder cancer
Kumar, S., Kumar, S., & Kumar, S. (2006) · Journal of Surgical Oncology · doi:10.1002/jso.20530 · Cited by 119 · cited 1× · see citing works
“These chronic infections increase the risk of several gastrointestinal(138) diseases, including chronic cholecystitis and gallbladder cancer.(139,140) Recently, Kato et al reported that antibody against Salmonella flagellin was higher in colorectal cancer and pre-cancer cases than controls in two distinct populations…”
BackgroundMetagenomic profile of gut microbiota in children during cholera and recovery
Monira, S., Nakamura, S., Gotoh, K., Izutsu, K., Watanabe, H., Alam, N., Nakaya, T., Horii, T., Ali, S. I., Iida, T., et al. (2013) · Gut Pathogens · doi:10.1186/1757-4749-5-1 · Cited by 119 · see citing works
Corredoira, J., Garcı́a-Garrote, F., Rey, R. R., López-Rosés, L., García-Pais, M. J., Gracián-Castro, E., González-Soler, R., Coira, A., Pita, J., Lopez-Alvarez, M. J., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis434 · Cited by 116 · see citing works
Corredoira, J., Alonso, M. P., García, J. F., Casariego, E., Coira, A., Rodríguez, A., Pita, J., Louzao, C., Pombo, B., López, M. J., et al. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-1314-x · Cited by 112 · see citing works
Probiotics for the Treatment of Inflammatory Bowel Disease
Veerappan, G. R., Betteridge, J. D., & Young, P. E. (2012) · Current Gastroenterology Reports · doi:10.1007/s11894-012-0265-5 · Cited by 111 · see citing works
Fite, A., Macfarlane, S., Furrie, E., Bahrami, B., Cummings, J. H., Steinke, D. T., & Macfarlane, G. T. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.02574-12 · Cited by 110 · cited 1× · see citing works
“However, there have been only sporadic studies reporting a significant association with colorectal cancer itself,(101,102) while others found higher prevalence or density of these bacteria in IBD than in controls, which was further correlated with disease activity.(4,103,104) In addition to F.”
ResultSchlegel, L., Grimont, F., COLLINS, M. D., Regnault, B., Grimont, P. A. D., & Bouvet, A. (2000) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/00207713-50-4-1425 · Cited by 110 · cited 3× · see citing works
“Approximately 10% of healthy individuals have been estimated to carry this bacterium asymptomatically in their digestive tract.(20) While fecaleoral or oraleoral is a possible transmission route between humans, it may be acquired through dietary intake of ruminant-derived foods, such as unpasteurized dairy products,(2…”
BackgroundBacterial activation of β-catenin signaling in human epithelia
Sun, J., Hobert, M. E., Rao, A. S., Neish, A. S., & Madara, J. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00498.2003 · Cited by 105 · see citing works
Selective Inhibition of Type III Secretion Activated Signaling by the Salmonella Effector AvrA
Du, F., & Galán, J. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000595 · Cited by 104 · see citing works
Wu, Q., Yang, Z., Xu, P., Gao, L., & Fan, D. (2013) · Colorectal Disease · doi:10.1111/codi.12284 · Cited by 102 · see citing works
Abdulamir, A. S., Hafidh, R. R., Mahdi, L. K., Al-jeboori, T., & Abubaker, F. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-403 · Cited by 100 · see citing works
Tjalsma, H., Schöller‐Guinard, M., Lasonder, E., Ruers, T. J. M., Willems, H. L., & Swinkels, D. W. (2006) · International Journal of Cancer · doi:10.1002/ijc.22116 · Cited by 97 · see citing works
Corredoira, J., Alonso, M. P., Coira, A., Casariego, E., Arias, C. A., Alonso, D., Pita, J., Rodríguez, A., López, M. J., & Varela, J. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0441-y · Cited by 89 · see citing works
Co-occurrence of driver and passenger bacteria in human colorectal cancer
Geng, J., Song, Q., Tang, X., Xiao, L., Fan, H., Peng, H., Guo, Q., & Zhang, Z. (2014) · Gut Pathogens · doi:10.1186/1757-4749-6-26 · Cited by 89 · see citing works
Rates of production and utilization of lactate by microbial communities from the human colon
Belenguer, Á., Holtrop, G., Duncan, S. H., Anderson, S. E., Calder, A. G., Flint, H. J., & Lobley, G. E. (2011) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2011.01086.x · Cited by 85 · see citing works
Helicobacter pylori in colorectal neoplasms: is there an aetiological relationship?
Jones, M., Helliwell, P., Pritchard, C. W., Tharakan, J., & Mathew, J. (2007) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-5-51 · Cited by 85 · see citing works
Burns, C., McCaughey, R. S., & Lauter, C. B. (1985) · PubMed · Cited by 82 · see citing works
Association of Streptococcus bovis Bacteremia with Bowel Disease
Reynolds, J. G., da Silva, E. T. G., & McCormack, W. M. (1983) · Journal of Clinical Microbiology · doi:10.1128/jcm.17.4.696-697.1983 · Cited by 82 · see citing works
Bongers, G., Pacer, M. E., Geraldino, T. H., Chen, L., He, Z., Hashimoto, D., Furtado, G. C., Ochando, J., Kelley, K. A., Clemente, J. C., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131587 · Cited by 78 · cited 1× · see citing works
“This study indicates that the same genetic mutation in different individuals may have a different outcome.(152) One environmental factor e a diet low in fiber e may impact the intestinal microbiota in a way that affects host cell physiology, cellular homeostasis, energy regulation, and/or metabolism of xenobiotics.”
BackgroundSalmonella Promoters Preferentially Activated Inside Tumors
Arrach, N., Zhao, M. D., Porwollik, S., Hoffman, R. M., & McClelland, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0552 · Cited by 78 · cited 1× · see citing works
“In animal models, Salmonella and its derivatives have been observed invading transformed tissue more efficiently than normal tissue.(141,142) Salmonella AvrA is a multifunctional protein that influences eukaryotic cell pathways by altering ubiquitination and acetylation of target proteins.”
BackgroundCorredoira, J., Alonso, M. P., Coira, A., & Varela, J. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00129-08 · Cited by 74 · cited 1× · see citing works
“infantarius to non-colonic cancers, primarily in the pancreas and biliary tract.(19) Although SB is a member of normal gastrointestinal flora in ruminants, e.”
BackgroundInhibition by Resistant Starch of Red Meat–Induced Promutagenic Adducts in Mouse Colon
Winter, J. M., Nyskohus, L. S., Young, G. P., Hu, Y. C., Conlon, M. A., Bird, A. R., Topping, D. L., & Leu, R. K. L. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0176 · Cited by 74 · see citing works
Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers.
Limburg, P. J., Stolzenberg‐Solomon, R. Z., Colbert, L. H., Perez-Perez, G. I., Blaser, M. J., Taylor, P. R., Virtamo, J. R. K., & Albanes, D. (2002) · PubMed · Cited by 74 · see citing works
Association between Streptococcus bovis and Colon Cancer
Boleij, A., Schaeps, R. M. J., & Tjalsma, H. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01755-08 · Cited by 71 · cited 1× · see citing works
“These variations may also be due to the heterogeneous definition of the cases, as adenomas have been defined as diseased in some studies but not in the others.(46) A more recent study found that 52% of SB bacteremia patients had advanced adenoma/cancer, which was approximately 2.”
ResultGeographical difference of disease association in Streptococcus bovis bacteraemia
Lee, R. A., Woo, P. C. Y., To, A. P. C., Lau, S. K. P., Wong, S. S. Y., & Yuen, K. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05199-0 · Cited by 69 · see citing works
Prevalence of Liver Disease in Patients with Streptococcus bovis Bacteraemia
Gonzlez-Quintela, A., Martínez-Rey, C., Castroagudı́n, J. F., Rajo-Iglesias, M. C., & Domínguez‐Santalla, M. J. (2001) · Journal of Infection · doi:10.1053/jinf.2001.0799 · Cited by 65 · see citing works
A prospective study of plasma inflammatory markers and risk of colorectal cancer in men
Song, M., Wu, K., Ogino, S., Fuchs, C. S., Giovannucci, E. L., & Chan, A. T. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.172 · Cited by 63 · see citing works
Alazmi, W. M., Bustamante, M., O’Loughlin, C. J., González, J. D., & Raskin, J. B. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-3199-7 · Cited by 59 · see citing works
A prospective controlled study of the association of Streptococcus bovis with colorectal carcinoma.
Potter, M. A., Cunliffe, N. A., Smith, M. H., Miles, R., Flapan, A. D., & Dunlop, M. G. (1998) · Journal of Clinical Pathology · doi:10.1136/jcp.51.6.473 · Cited by 59 · see citing works
Characteristics and regional variations of group D streptococcal endocarditis in France
Giannitsioti, E., Chirouze, C., Bouvet, A., Béguinot, I., Delahaye, F., Mainardi, J., Célard, M., Mihaïla-Amrouche, L., Moing, V. L., & Hoen, B. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01753.x · Cited by 58 · see citing works
Clarridge, J. E., Attorri, S., Zhang, Q., & Bartell, J. G. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.4.1549-1552.2001 · Cited by 58 · see citing works
Increased exposure to bacterial antigen RpL7/L12 in early stage colorectal cancer patients
Boleij, A., Roelofs, R., Schaeps, R. M. J., Schülin, T., Glaser, P., Swinkels, D. W., Kato, I., & Tjalsma, H. (2010) · Cancer · doi:10.1002/cncr.25212 · Cited by 54 · see citing works
Serological investigation into the association between Streptococcus bovis and colonic cancer.
Darjee, R., & Gibb, A. P. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.12.1116 · Cited by 51 · see citing works
Butt, J., Romero‐Hernández, B., Pérez‐Gómez, B., Willhauck‐Fleckenstein, M., Holzinger, D., Martín, V., Moreno, V. R., Linares, C., Dierssen‐Sotos, T., Barricarte, A., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29914 · Cited by 51 · see citing works
Keithlin, J., Sargeant, J. M., Thomas, M. K., & Fazil, A. (2014) · Epidemiology and Infection · doi:10.1017/s0950268814002829 · Cited by 48 · see citing works
Fecal carriage of Streptococcus bovis and colorectal adenomas
Dubrow, R., Edberg, S. C., Wikfors, E., Callan, D. A., Troncale, F. J., Vender, R. J., Brand, M., & Yapp, R. G. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90531-o · Cited by 46 · see citing works
Partial associations of dietary iron, smoking and intestinal bacteria with colorectal cancer risk
Kato, I., Boleij, A., Kortman, G. A. M., Roelofs, R., Djuric, Z., Severson, R. K., & Tjalsma, H. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2013.748922 · Cited by 46 · see citing works
Bacteremic Streptococcus bovis infections at a university hospital, 1992-2001.
Jean, S., Teng, L., Hsueh, P., Ho, S. W., & Luh, K. T. (2004) · PubMed · Cited by 43 · see citing works
Wentling, G. K., Metzger, P. P., Dozois, E. J., Chua, H. K., & Krishna, M. (2006) · Diseases of the Colon & Rectum · doi:10.1007/s10350-006-0576-4 · Cited by 43 · see citing works
Boleij, A., Roelofs, R., Danne, C., Bellais, S., Dramsi, S., Kato, I., & Tjalsma, H. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0321 · Cited by 38 · see citing works
Sharara, A. I., Hamdan, T. A., Malli, A. H., El-Halabi, M. M., Hashash, J. G., Ghaith, O. A., & Kanj, S. S. (2013) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12059 · Cited by 28 · cited 2× · see citing works
“Similar prevalence (60%) of advanced adenoma/ cancer was reported in SB endocarditis patients by Sharara et al.(48) The second set of evidence is derived from studies comparing SB prevalence among various patient groups with or without colonic diseases.”
BackgroundWorthley, D. L., Whitehall, V., Leu, R. K. L., Irahara, N., Buttenshaw, R. L., Mallitt, K., Greco, S. A., Ramsnes, I., Winter, J. M., Hu, Y. C., et al. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1312-4 · Cited by 28 · see citing works
Inflammatory Bowel Disease and Streptococcus bovis
Teitelbaum, J. E., & Triantafyllopoulou, M. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-9053-5 · Cited by 24 · see citing works
Cancer Therapies Use a Little Help From Microbial Friends
Pennisi, E. (2013) · Science · doi:10.1126/science.342.6161.921 · Cited by 22 · see citing works
Streptococcus bovis septicaemia associated with uncomplicated colonic carcinoma
McMahon, A. J., Auld, C. D., Dale, B. A. S., Walls, A. D. F., & McCormick, J. S. (1991) · British journal of surgery · doi:10.1002/bjs.1800780734 · Cited by 22 · see citing works
Gentamicin-thallous-carbonate medium for isolation of fecal streptococci from foods
Thian, T. S., & Hartman, P. A. (1981) · Applied and Environmental Microbiology · doi:10.1128/aem.41.3.724-728.1981 · Cited by 20 · cited 1× · see citing works
“In fact SB is a frequently detected contaminant in commercially available meat.(23,24) The correlation between SB and colonic disease has long been recognized.”
BackgroundStreptococcs bovis Bacteremia and Digestive System Neoplasms
Pigrau, C., Lorente, A., Pahissa, A., & Martinez-Vazquez, J. M. (1988) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548809032490 · Cited by 20 · see citing works
Kato, I., Nechvatal, J. M., Dzinic, S. H., Basson, M. D., Majumdar, A. P. N., & Ram, J. L. (2010) · PubMed · Cited by 19 · see citing works
Efficient tumor targeting by anaerobic butyrate-producing bacteria
Tirandaz, H., & Mohammadi, E. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.01.024 · Cited by 17 · see citing works
Kim, S. Y., Joo, S.-I., Yi, J., & Kim, E. C. (2010) · Annals of Laboratory Medicine · doi:10.3343/kjlm.2010.30.2.160 · Cited by 16 · see citing works
Knudtson, L. M., & Hartman, P. A. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.3.936-938.1993 · Cited by 14 · see citing works
Streptococcus bovis bacteremia related to colon adenoma in a chronic hemodialysis patient
Kahveci, A., Arı, E., Arikan, I. H., Koç, M., Tuğlular, S., & Ozener, C. I. (2009) · Hemodialysis International · doi:10.1111/j.1542-4758.2009.00400.x · Cited by 8 · see citing works
The influence of endoscopic procedures upon the contamination of Helicobacter pylori cultures
Ribeiro, M. L., Godoy, A. P. O., Benvengo, Y. H. B., Ecclissato, C., Mendonça, S., & Pedrazzoli, J. (2004) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032004000200006 · Cited by 6 · cited 1× · see citing works
“, cattle, sheep, horses, pigs, camels and deers, it is also found in human feces as well as gastric biopsy materials.(20,21) Approximately 10% of healthy individuals have been estimated to carry this bacterium asymptomatically in their digestive tract.”
BackgroundCheng, H., Zhang, T., Gu, W., Shu, X., Zhang, Y., Zhang, X., Wu, X., Chen, J., & Jiang, M. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182467538 · Cited by 6 · see citing works
[Molecular-biological methods of diagnosing colon-related Streptococcus bovis endocarditis].
Nielsen, S. D., Christensen, J. J., Laerkeborg, A., Haunsø, S., & Knudsen, J. D. (2007) · PubMed · Cited by 5 · see citing works
Flagged first, then by citations
1 of the 170 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- [45]Beck M. Frodl R. Funke G. Comprehensive study of strains previously designated Streptococcus bovis consecutively isolated from human blood cultures and emended description of Streptococcus gallolyticus and Streptococcus infantarius subsp. coli J Clin Microbiol 46 2008 2966 2972 18614655 PMC2546750
- [72]Martin H.M. Campbell B.J. Hart C.A. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer Gastroenterology 127 2004 80 93 15236175
Cited by
Sorted by citations
NF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679 · see citing works
Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer
Song, M., Chan, A. T., & Sun, J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.06.048 · Cited by 752 · see citing works
The Gut Microbiota and Inflammation: An Overview
Bander, Z. A., Nitert, M. D., Mousa, A., & Naderpoor, N. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17207618 · Cited by 783 · see citing works
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 772 · see citing works
Salguero, M. V., Al-Obaide, M. A. I., Singh, R., Siepmann, T., & Vasylyeva, T. L. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7943 · Cited by 258 · see citing works
“The present study identified five previously reported genera in the phylum Bacteroidetes, including Porphyromonas , Prevotella , Paraprevotella and Flavobacterium (38,39).”
The Mechanism of Bacteroides fragilis Toxin Contributes to Colon Cancer Formation
Cheng, W. T., Kantilal, H. K., & Davamani, F. A. (2020) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2020.27.4.2 · Cited by 244 · see citing works
Oral–Gut Microbiome Axis in Gastrointestinal Disease and Cancer
Park, S.-Y., Hwang, B.-O., Lim, M., Ok, S.-H., Lee, S., Chun, K., Park, K.-K., Hu, Y., Chung, W., & Song, N. (2021) · Cancers · doi:10.3390/cancers13092124 · Cited by 237 · see citing works
Mucosa-associated microbiota dysbiosis in colitis associated cancer
Richard, M. L., Liguori, G., Lamas, B., Brandi, G., Costa, G. D., Hoffmann, T. W., Simone, M. P. D., Calabrese, C., Poggioli, G., Langella, P., et al. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1379637 · Cited by 214 · see citing works
“Colorectal cancer (CRC) is the third commonest cancer type worldwide with, every year, 1,360,000 new cases and 600,000 deaths.(1,2) Its incidence rate is rapidly rising in less developed regions, with a poorer prognosis compared to western countries where routine diagnosis have been efficient in reducing the incidence…”
BackgroundXie, Y., Gao, Q., Cai, G. X., Sun, X. M., Zou, T.-H., Chen, H. M., Yu, S.-Y., Qiu, Y.-W., Gu, W.-Q., Chen, X. Y., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.10.005 · Cited by 192 · see citing works
“…or her genetic status, feeding pattern, age, gender, dietary habit, health situation, drug intake and wealth level, making gut microbiota a highly potential biomarker (Ding and Schloss, 2014, Costello et al., 2009, Quigley, 2017, Sun and Kato, 2016, Peters et al., 2016, Yatsunenko et al., 2012).”
BackgroundMicrobiota’s role in health and diseases
El-Sayed, A., Aleya, L., & Kamel, M. S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-14593-z · Cited by 195 · see citing works
“This is attributed to the higher microbial population in the large intestine, especially the gut virome and bacteriophages (Dahiya and Renuka 2017; Sun and Kato 2016).”
BackgroundUnderstanding the role of the gut microbiome in gastrointestinal cancer: A review
Ağagündüz, D., Cocozza, E., Cemali, Ö., Bayazıt, A. D., Nanì, M. F., Cerqua, I., Morgillo, F., Saygılı, S. K., Berni Canani, R., Amero, P., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1130562 · Cited by 189 · see citing works
“Cancer prevention is the main target, and it is reported that a better understanding of the interactions between gut microbiota, barrier function, and inflammatory responses is significant in identifying new targets in cancer therapy (Bultman, 2016; Sun and Kato, 2016).”
BackgroundGastro-Intestinal and Oral Microbiome Signatures Associated with Healthy Aging
Singh, H., Torralba, M. G., Moncera, K. J., DiLello, L., Petrini, J., Nelson, K. E., & Pieper, R. (2019) · GeroScience · doi:10.1007/s11357-019-00098-8 · Cited by 158 · see citing works
Bader, J. E., Enos, R. T., Velázquez, K. T., Carson, M. S., Nagarkatti, M., Nagarkatti, P. S., Chatzistamou, I., Davis, J. M., Carson, J. A., Robinson, C. M., et al. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00229.2017 · Cited by 170 · see citing works
Triner, D. A., Devenport, S. N., Ramakrishnan, S. K., Ma, X., Frieler, R. A., Greenson, J. K., Inohara, N., Núñez, G., Colacino, J. A., Mortensen, R. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.12.003 · Cited by 167 · see citing works
Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer
Fan, X., Jin, Y., Chen, G., Ma, X., & Zhang, L. (2020) · Digestion · doi:10.1159/000508328 · Cited by 169 · see citing works
Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities
Pandey, H., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Cancers · doi:10.3390/cancers15030866 · Cited by 165 · see citing works
“The Firmicutes/Bacteroidetes ratio (Bacillota/Bacteroidota) has been used as a critical parameter for gut health [53] and is critical for CRC progression [54].”
MethodLinking Obesity with Colorectal Cancer: Epidemiology and Mechanistic Insights
Ye, P., Xi, Y., Huang, Z., & Xu, P. (2020) · Cancers · doi:10.3390/cancers12061408 · Cited by 160 · see citing works
“for gastrointestinal health to maintain intestinal barrier function [136].”
BackgroundPolyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer
Mileo, A. M., Nisticò, P., & Miccadei, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00729 · Cited by 152 · see citing works
Linking Gut Microbiota to Colorectal Cancer
Raskov, H., Burcharth, J., & Pommergaard, H. (2017) · Journal of Cancer · doi:10.7150/jca.20497 · Cited by 151 · see citing works
Šarenac, T., & Mikov, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00484 · Cited by 143 · see citing works
Green Tea Liquid Consumption Alters the Human Intestinal and Oral Microbiome
Yuan, X., Long, Y., Ji, Z., Gao, J., Fu, T., Yan, M., Zhang, L., Su, H., Zhang, W., Wen, X., et al. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800178 · Cited by 142 · see citing works
Hu, L., Liu, Y., Kong, X., Wu, R., Peng, Q., Zhang, Y., Zhou, L., & Duan, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658681 · Cited by 141 · see citing works
“Recently, accumulating evidence by metagenome-wide association studies indicated an association between gut microbiota dysbiosis and CRC, and enteropathogenic microorganism plays a role in shaping the inflammatory environment and promoting tumor initiation and progression (4, 5).”
BackgroundGethings-Behncke, C., Coleman, H. G., Jordão, H. W. T., Longley, D. B., Crawford, N., Murray, L., & Kunzmann, A. T. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-1295 · Cited by 137 · see citing works
“A number of bacterial species have been implicated with colorectal cancer onset, including Helicobacter pylori, Escherichia coli, Bacteroides fragilis, Salmonella enterica, and Fusobacterium nucleatum (3).”
BackgroundInfluentialEfficient inter-species conjugative transfer of a CRISPR nuclease for targeted bacterial killing
Hamilton, T. A., Pellegrino, G. M., Therrien, J. A., Ham, D. T., Bartlett, P. C., Karas, B. J., Gloor, G. B., & Edgell, D. R. (2019) · Nature Communications · doi:10.1038/s41467-019-12448-3 · Cited by 134 · see citing works
Mukherjee, S., Joardar, N., Sengupta, S., & Babu, S. P. S. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.07.010 · Cited by 127 · see citing works
“Several current studies that assessed beta diversity through 16S rRNA sequencing have illustrated structural differences amongst the gut microbiota, where samples belonging to different disease status (cancer, adenoma, or control/normal adjacent tissue) cluster in different two-dimensional spaces indicating the presen…”
BackgroundMicrobiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases
Miller, A. L., Bessho, S., Grando, K. C. M., & Tükel, Ç. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.638867 · Cited by 131 · see citing works
“Specific changes within the intestinal microbial community are observed in CRC patients, such as increased abundance of Fusobacteria, Alistipes, Porphyromonadaceae, Coriobacteridae, Staphylococcaceae, Akkermansia, and Methanobacteriales, while representation of Bifidobacterium, Lactobacillus, Ruminococcus, Faecalibact…”
BackgroundBlueprint for cancer research: Critical gaps and opportunities
Elmore, L. W., Greer, S. F., Daniels, E. C., Saxe, C. C., Melner, M. H., Krawiec, G. M., Cance, W. G., & Phelps, W. C. (2020) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21652 · Cited by 121 · see citing works
Gut microbiota-derived metabolites in CRC progression and causation
Dalal, N., Jalandra, R., Bayal, N., Yadav, A. K., Harshulika, Sharma, M., Makharia, G. K., Kumar, P., Singh, R. K., Solanki, P. R., et al. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03729-w · Cited by 102 · see citing works
“P. anaerobius is normally harmless but it may be harmful in immunocompromised conditions (Sun and Kato 2016).”
BackgroundAghamajidi, A., & Vareki, S. M. (2022) · Cancers · doi:10.3390/cancers14153563 · Cited by 102 · see citing works
“In addition, the immune dysregulation caused by other commensal microbial species such as Streptococcus gallolyticus, Enterococcus faecalis, Bacteroides fragilis, and Fusobacterium nucleatum also contribute to CRC development [65].”
BackgroundVitamin D Receptor Influences Intestinal Barriers in Health and Disease
Sun, J., & Zhang, Y. (2022) · Cells · doi:10.3390/cells11071129 · Cited by 100 · see citing works
Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment
Liu, Y., Lau, H. C.-H., Cheng, W. Y., & Yu, J. Q. (2022) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2022.07.002 · Cited by 98 · see citing works
“Bacteria-derived signals identified by PRRs can activate downstream inflammatory signaling pathways, including nuclear factor kappa-lightchain-enhancer of activated B cells (NF-jB), mitogenactivated protein kinase (MAPK), and signal transducer and activator of transcription 3 (STAT3) which are all important pathways t…”
BackgroundAlterations in the gut bacterial microbiome in fungal Keratitis patients
Chakravarthy, S. K., Jayasudha, R., Ranjith, K., Dutta, A., Pinna, N. K., Mande, S. S., Sharma, S., Garg, P., Murthy, S. I., & Shivaji, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199640 · Cited by 88 · see citing works
Rizzato, C., Torres, J., Kasamatsu, E., Camorlinga‐Ponce, M., Bravo, M. M., Canzian, F., & Kato, I. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00846 · Cited by 81 · see citing works
“infective endocarditis on cardiac valves (Boleij et al., 2010, 2012; Sun and Kato, 2016; Butt et al., 2018; Jans and Boleij, 2018).”
BackgroundNiccolai, E., Russo, E., Baldi, S., Ricci, F., Nannini, G., Pedone, M., Stingo, F. C., Taddei, A., Ringressi, M. N., Bechi, P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.573158 · Cited by 78 · see citing works
The gut microbiota and endometriosis: From pathogenesis to diagnosis and treatment
Qin, R., Tian, G., Liu, J., & Cao, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1069557 · Cited by 77 · see citing works
“Studies have found that gut microbiota disorders can not only cause inflammatory bowel disease, irritable bowel syndrome, and colon cancer in the intestinal system, but can also induce diseases in the extraintestinal system, such as diabetes, mastitis, and polycystic ovary syndrome (Baothman et al., 2016; Sun and Kato…”
BackgroundImplication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer
Singh, S., Sharma, P., Sarma, D. K., Kumawat, M., Tiwari, R. R., Verma, V., Nagpal, R., & Kumar, M. (2023) · Cancers · doi:10.3390/cancers15061913 · Cited by 80 · see citing works
Microbiota and Cancer: The Emerging Beneficial Role of Bifidobacteria in Cancer Immunotherapy
Longhi, G., van Sinderen, D., Ventura, M., & Turroni, F. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.575072 · Cited by 71 · see citing works
“(2020). The infant gut microbiome as a microbial organ influencing host well-being.”
BackgroundA Pilot Study: Changes of Gut Microbiota in Post-surgery Colorectal Cancer Patients
Cong, J., Zhu, H., Liu, D., Li, T., Zhang, C., Zhu, J., Lv, H., Liu, K., Hao, C., Tian, Z., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02777 · Cited by 69 · see citing works
“, 2011), and is influenced by heredity, diet, lifestyle, gut microbiota, and other factors (Berstad et al., 2015; Sun and Kato, 2016).”
BackgroundZhong, H., Jiang, J., Hussain, M., Zhang, H., Ling, C., & Guan, R. (2025) · Advanced Science · doi:10.1002/advs.202500304 · Cited by 66 · see citing works
Caffeine and its main targets of colorectal cancer
Cui, W., Wang, S.-T., Pan, D., Chang, B., & Sang, L.-X. (2020) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i2.149 · Cited by 66 · see citing works
Fernández, J., Ledesma, E., Monte, J., Millán, E., Costa, P., de la Fuente, V. G., García, M. T. F., Martínez‐Camblor, P., Villar, C. J., & Lombó, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-51437-w · Cited by 65 · see citing works
New insights into microbial bile salt hydrolases: from physiological roles to potential applications
Dong, Z., Yang, S., Tang, C., Li, D., Kan, Y., & Yao, L. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1513541 · Cited by 64 · see citing works
“…(Figure 1), which may promote colorectal cancer, cause DNA damage and reactive oxygen species-associated oxidative stress in epithelial intestinal cells, or lead to impaired colonic mucosal function that would cause diarrhea, inflammation, and some other GIT diseases (Sun and Kato, 2016).”
Zhang, Y., Garrett, S., Carroll, R. E., Xia, Y., & Sun, J. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00502-1 · Cited by 63 · see citing works
Oral and Gut Microbial Carbohydrate-Active Enzymes Landscape in Health and Disease
Onyango, S. O., Juma, J., Paepe, K. D., & de Wiele, T. V. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.653448 · Cited by 61 · see citing works
“Potentially, this reduces the generation of short-chain fatty acids such as butyrate which has also been reported to reduce the risk for cancer development (Sun and Kato, 2016).”
BackgroundWang, T., Zhang, L., Wang, P., Liu, Y., Wang, G., Shan, Y., Yi, Y., Zhou, Y., Liu, B., Wang, X., et al. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02627-8 · Cited by 61 · see citing works
“In addition, SCFAs, especially butyric acid, have been proved to have potential benefits for CA-CRC patients as they could promote and maintain colonic epithelial health [32], moderate cell growth and differentiation [45], inhibit histone deacetylases in colonocytes and immune cells [46] and exert anti-inflammatory ef…”
BackgroundEffect of industrial trans-fatty acids-enriched diet on gut microbiota of C57BL/6 mice
Ge, Y., Liu, W., Tao, H., Zhang, Y., Liu, L., Liu, Z., Qiu, B., & Xu, T. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1810-2 · Cited by 63 · see citing works
Tacconi, E., Palma, G., Biase, D. D., Luciano, A., Barbieri, M., de Nigris, F., & Bruzzese, F. (2023) · Nutrients · doi:10.3390/nu15030563 · Cited by 62 · see citing works
A Systematic Overview of Type II and III Toxin-Antitoxin Systems with a Focus on Druggability
Kang, S., Kim, D., Jin, C., & Lee, B. (2018) · Toxins · doi:10.3390/toxins10120515 · Cited by 60 · see citing works
tRNA Queuosine Modification Enzyme Modulates the Growth and Microbiome Recruitment to Breast Tumors
Zhang, J., Lu, R., Zhang, Y., Matuszek, Ż., Zhang, W., Xia, Y., Pan, T., & Sun, J. (2020) · Cancers · doi:10.3390/cancers12030628 · Cited by 60 · see citing works
“Tight junction proteins are the key players in the epithelial barrier function in inflammatory bowel disease [38-42].”
BackgroundStructure of the Mucosal and Stool Microbiome in Lynch Syndrome
Yan, Y., Drew, D. A., Markowitz, A. J., Lloyd‐Price, J., Abu-Ali, G., Nguyen, L. H., Tran, C., Chung, D. C., Gilpin, K. K., Meixell, D. A., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.005 · Cited by 63 · see citing works
Immunometabolism in biofilm infection: lessons from cancer
Mirzaei, R., Sabokroo, N., Ahmadyousefi, Y., Motamedi, H., & Karampoor, S. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00435-2 · Cited by 59 · see citing works
Aceto, G. M., Catalano, T., & Curia, M. C. (2020) · BioMed Research International · doi:10.1155/2020/1726309 · Cited by 57 · see citing works
Gut microbiota modulation: a tool for the management of colorectal cancer
Wang, Y., & Li, H. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03378-8 · Cited by 57 · see citing works
“Mainly, three mechanisms have been identified for tumor-promoting activities of microbiota: pathogenic bacterial virulence factors/toxins, bacterial metabolic products, and immune modulation/reaction [18].”
BackgroundYu, L., Cui, A., & Zhang, X. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2348441 · Cited by 53 · see citing works
Multi-omics machine learning to study host-microbiome interactions in early-onset colorectal cancer
Jayakrishnan, T., Sangwan, N., Barot, S. V., Farha, N., Mariam, A., Shao, X., Aucejo, F., Conces, M. L., Nair, K. G., Krishnamurthi, S., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00647-1 · Cited by 51 · see citing works
Heterogeneity of colon cancer: from bench to bedside
Merlano, M. C., Granetto, C., Fea, E., Ricci, V., & Garrone, O. (2017) · ESMO Open · doi:10.1136/esmoopen-2017-000218 · Cited by 51 · see citing works
Streptomyces, shared microbiome member of soil and gut, as ‘old friends’ against colon cancer
Bolourian, A., & Mojtahedi, Z. (2018) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiy120 · Cited by 49 · see citing works
Wang, X., Yu, N., Wang, Z., Qiu, T., Jiang, L., Zhu, X., Sun, Y., & Xiong, H. (2020) · Food & Function · doi:10.1039/c9fo02917f · Cited by 49 · see citing works
The influence of blood on the human gut microbiome
Chénard, T., Malick, M., Dubé, J., & Massé, É. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01724-8 · Cited by 48 · see citing works
Yang, L., Xie, X., Li, Y., Wu, L., Fan, C., Liang, T., Xi, Y., Yang, S., Li, H., Zhang, J., et al. (2021) · Nutrients · doi:10.3390/nu13061982 · Cited by 47 · see citing works
Fang, C., Chen, J., Hsu, B., Hussain, B., Rathod, J., & Lee, K. (2021) · Microorganisms · doi:10.3390/microorganisms9081548 · Cited by 47 · see citing works
“Similarly, other common bacteria of the human gut, such as Streptococcus gallolyticus and Helicobacter pylori, are believed to be involved in colorectal cancer [26].”
BackgroundTajasuwan, L., Kettawan, A., Rungruang, T., Wunjuntuk, K., & Prombutara, P. (2023) · Nutrients · doi:10.3390/nu15061528 · Cited by 50 · see citing works
“The gut microbiota is vital in maintaining intestinal homeostasis [2].”
BackgroundVeljković, B. P., Djordjević, N. Z., Dolicanin, Z. C., Ličina, B., Topuzović, M. D., Stanković, M. S., Zlatić, N. M., & Stevanović, Z. D. (2018) · Notulae Botanicae Horti Agrobotanici Cluj-Napoca · doi:10.15835/nbha47111274 · Cited by 47 · see citing works
“There are some recent reports on linkage between gut microbiome and colorectal cancer (Sun and Kato, 2016), including the role of E.”
BackgroundNovel Regulatory Roles of Wnt1 in Infection-Associated Colorectal Cancer
Wang, J., Lu, R., Fu, X., Dan, Z., Zhang, Y., Chang, X., Liu, Q., Xia, Y., Liu, X., & Sun, J. (2018) · Neoplasia · doi:10.1016/j.neo.2018.03.001 · Cited by 45 · see citing works
“001 Introduction Growing interest and accumulating data on human microbiota indicate that host-microbe interplay has an important role in the development of colorectal cancer (CRC) [1], which suggests that chronic infection and inflammation contribute to tumor initiation and tumor progression [2].”
BackgroundPotential biomarkers associated with oxidative stress for risk assessment of colorectal cancer
Mandal, P. (2017) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-017-1352-9 · Cited by 43 · see citing works
“Cespedes Feliciano et al. (2016) reported that the effects of obesity and metabolic dysregulation on cancer survival are inconsistent with metabolic syndrome (MetSyn).”
BackgroundBile acids as carcinogens in the colon and at other sites in the gastrointestinal system
Bernstein, H., & Bernstein, C. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221131858 · Cited by 43 · see citing works
von Frieling, J., Fink, C., Hamm, J., Klischies, K., Förster, M., Bosch, T. C. G., Roeder, T., Rosenstiel, P. C., & Sommer, F. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02020 · Cited by 44 · see citing works
“This topic is extensively covered by excellent recent publications to which we refer to for further reading (Shebl et al., 2012; Antonic et al., 2013; Cummins and Tangney, 2013; Sun and Kato, 2016; Pasquereau-Kotula et al., 2018).”
BackgroundEscherichia coli and Colorectal Cancer: Unfolding the Enigmatic Relationship
Rezaee, M. A., Nouri, R., Hasani, A., Shirazi, K. M., Alivand, M. R., Sepehri, B., Sotoodeh, S., & Hemmati, F. (2021) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201022666210910094827 · Cited by 45 · see citing works
Microbiota and epigenetics: promising therapeutic approaches?
El-Sayed, A., Aleya, L., & Kamel, M. S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-15623-6 · Cited by 41 · see citing works
“In addition to breast cancer, a clear relationship between microbiota and other cancer types was described in the literature where the microbiome is involved directly/indirectly, completely/partially in the induction of different cancer types affecting the digestive tract (Borges-Canha et al. 2015; Dahiya and Renuka 2…”
BackgroundThe Effect of Microbiota on Colon Carcinogenesis
Yoon, K., & Kim, N. (2018) · Journal of Cancer Prevention · doi:10.15430/jcp.2018.23.3.117 · Cited by 41 · see citing works
“Adapted from Sun and Kato.(15) COLORECTAL NEOPLASM”
BackgroundInfluence of Iron on the Gut Microbiota in Colorectal Cancer
Phipps, O., Al-Hassi, H. O., Quraishi, M. N., Kumar, A., & Brookes, M. (2020) · Nutrients · doi:10.3390/nu12092512 · Cited by 41 · see citing works
“Cancer occurrence in the large intestines is approximately 12-fold higher than the small intestines [33].”
BackgroundXi, Y., Jing, Z., Wu, W., Zhang, C., Quan, Q., Zhou, Q., Jiamin, X., & Han, S. (2021) · BMC Cancer · doi:10.1186/s12885-021-07845-1 · Cited by 40 · see citing works
Huang, Z., Yang, W., Wang, X., Guo, F., Cheng, Y., Cao, L., Zhu, W., Sun, Y., & Xiong, H. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c00585 · Cited by 39 · see citing works
Xia, W., Liu, B., Tang, S., Yasir, M., & Khan, I. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.875513 · Cited by 39 · see citing works
“A balanced GM is key to host health, and any dysbiosis in gut microbial composition could put the host at a risk for obesity, inflammatory bowel disease, diabetes, autism, rheumatoid arthritis, and colorectal cancer (CRC) (Musso et al., 2010; Stefka et al., 2014; Sun and Kato, 2016; Maeda and Takeda, 2017).”
BackgroundColorectal cancer: The epigenetic role of microbiome
Sabit, H., Çevik, E., & Tombuloğlu, H. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i22.3683 · Cited by 39 · see citing works
Oral–Gut Microbiome Axis in Gastrointestinal Disease and Cancer
Park, S.-Y., Hwang, B.-O., Lim, M., Ok, S. H., Lee, S., Chun, K., Park, K.-K., Hu, Y., Chung, W., & Song, N. (2021) · Cancers · doi:10.3390/cancers13071748 · Cited by 43 · see citing works
Molecular mechanistic pathway of colorectal carcinogenesis associated with intestinal microbiota
Mandal, P. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.12.008 · Cited by 38 · see citing works
Influence of Gut Microbiota-Mediated Immune Regulation on Response to Chemotherapy
Deng, Y., Hou, X., Wang, H., Du, H., & Liu, Y. (2024) · Pharmaceuticals · doi:10.3390/ph17050604 · Cited by 37 · see citing works
“SCFAs also promote the differentiation of T-cells into effector T-cells (Th1 and Th17 cell) [94,104].”
BackgroundMudd, A. M., Gu, T., Munagala, R., Jeyabalan, J., Egilmez, N. K., & Gupta, R. C. (2019) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-19-0362 · Cited by 37 · see citing works
“enterica), and enterotoxigenic Bacteriodes fragilis (ETBF) (9).”
Wang, T., Wang, P., Ge, W., Shi, C., Xiao, G., Wang, X., & Lü, X. (2021) · Food & Function · doi:10.1039/d1fo01531a · Cited by 37 · see citing works
Mechanism of Bile Acid-Induced Programmed Cell Death and Drug Discovery against Cancer: A Review
Jang, J. Y., Im, E., Choi, Y. H., & Kim, N. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137184 · Cited by 36 · see citing works
“UDCA is the most hydrophilic bile acid, while DCA and LCA are the least polar and most toxic bile acids that can contribute to the development of colorectal cancer [45].”
BackgroundRole of preoperative gut microbiota on colorectal anastomotic leakage: preliminary results
Palmisano, S., Campisciano, G., Iacuzzo, C., Bonadio, L., Zucca, A., Cosola, D., Comar, M., & de Manzini, N. (2020) · Updates in Surgery · doi:10.1007/s13304-020-00720-x · Cited by 37 · see citing works
“Finally, as in the literature several studies show that the colorectal microbiota of individuals affected by cancer presents a decreased level of biodiversity [3, 6, 33], we analyzed the α-diversity.”
ResultRegulation of tissue-resident memory T cells by the Microbiota
Overacre-Delgoffe, A. E., & Hand, T. W. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00491-1 · Cited by 37 · see citing works
Huang, Q., Wei, X., Li, W., Ma, Y., Chen, G., Zhao, L., Jiang, Y., Xie, S., Chen, Q., & Chen, T. (2022) · Cancers · doi:10.3390/cancers14215178 · Cited by 35 · see citing works
“Accumulating evidence has shown that microbiota is viewed as an increasingly important factor in the initiation and progression of many diseases, including cancer [15–18].”
BackgroundConnect between gut microbiome and diseases of the human eye
Shivaji, S. (2019) · Journal of Biosciences · doi:10.1007/s12038-019-9931-1 · Cited by 35 · see citing works
Ibrahim, I. A. A., Alzahrani, A. R., Alanazi, I. M., Shahzad, N., Shahid, I., Falemban, A. H., Azlina, M. F. N., & Arulselvan, P. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126581 · Cited by 34 · see citing works
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities
Jandl, B., Dighe, S. N., Gasché, C., Makristathis, A., & Muttenthaler, M. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00133-23 · Cited by 35 · see citing works
“Within the B. fragilis group, enterotoxigenic B. fragilis is of particular clinical relevance, representing the most common carcinogenic bacteria and a pivotal pathogen implicated in the initiation and progression of colorectal cancers (177–179).”
Andrade, A. I. C., Rivera-Bautista, C., Ruiz‐Cabrera, M. A., Guerra, R. E. S., Chávez, E. G., Ahumada, C. F., & Grajales‐Lagunes, A. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.06.045 · Cited by 34 · see citing works
Chou, Y.-C., Ho, P.-Y., Chen, W.-J., Wu, S.-H., & Pan, M. (2020) · PubMed Central · Cited by 34 · see citing works
Wang, T., Zheng, J., Dong, S., Ismael, M., Shan, Y., Wang, X., & Lü, X. (2022) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-022-09967-9 · Cited by 34 · see citing works
“As the typical beneficial metabolites of intestinal microbiota, SCFAs (especially butyric acid) played important roles in ameliorating CRC [30], including inhibiting inflammation and histone deacetylases [31, 32], maintaining colonic epithelial health [33], inhibiting microbial pathogens [34], and regulating cell grow…”
BackgroundThe gastrointestinal microbiota in colorectal cancer cell migration and invasion
Henstra, C., van Praagh, J., Olinga, P., & Nagelkerke, A. (2021) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10130-x · Cited by 32 · see citing works
“coli, as a commensal, coexists peacefully with its mammalian host, promoting healthy intestinal homeostasis and causing disease only rarely [112].”
BackgroundImpact of bacterial infection and intestinal microbiome on colorectal cancer development
Sun, J. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001979 · Cited by 33 · see citing works
“Factors that affect the risk of CRC also affect the intestinal microbiome, including obesity; physical activity; and dietary intake of fiber, whole grains, and red and processed meat.([89,95]) These factors, including Salmonella infection,([96]) alter microbiome structure and function, along with the metabolic and imm…”
BackgroundIchim, T. E., Kesari, S., & Shafer, K. (2018) · Oncotarget · doi:10.18632/oncotarget.25778 · Cited by 33 · see citing works
Saha, B., Rithi, A. T., Adhikary, S., Banerjee, A., Radhakrishnan, A., Duttaroy, A. K., & Pathak, S. (2024) · Nutrition and Cancer · doi:10.1080/01635581.2024.2367266 · Cited by 37 · see citing works
The clinical application of fruquintinib on colorectal cancer
Chen, Z., & Jiang, L. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1630272 · Cited by 32 · see citing works
An age stratified analysis of the biomarkers in patients with colorectal cancer
Yao, H. Q., Li, C., & Tan, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-01850-x · Cited by 32 · see citing works
Li, C., Gao, Y., Huan, Y., Ren, P., Zhi, J., Wu, A., Xu, J., Wei, Z., Xue, C., & Tang, Q. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111324 · Cited by 32 · see citing works
Shen, J., Li, P., Liu, S., Liu, Q., Li, Y., Zhang, Z., Yang, C., Hu, M., Sun, Y., He, C., et al. (2020) · Food & Function · doi:10.1039/d0fo01731k · Cited by 31 · see citing works
Immunomodulatory Effect of Lactobacillus casei in a Murine Model of Colon Carcinogenesis
Casas‐Solís, J., Huizar-López, M. D. R., Irecta-Nájera, C. A., Pita‐López, M. L., & Santerre, A. (2019) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-019-09611-z · Cited by 31 · see citing works
Microbial factors in inflammatory diseases and cancers
Ong, H. S., & Yim, H. C. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5987-2_7 · Cited by 29 · see citing works
- Authors
- Sun, J., & Kato, I.
- Affiliations
- University of Illinois Chicago (US)
- Wayne State University (US)
- Corresponding author
- Sun, Jun
- ORCID
- Venue
- Genes & Diseases
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 3
- Issue
- 2
- Pages
- 130-143
- ISSN
- 2352-3042 (ISSN-L)
- PMC
- PMC5221561
- OpenAlex
- W2338446464
- Cited by
- 257
- References
- 170
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 25 · 2023: 27 · 2022: 34 · 2021: 29 · 2020: 39 · 2019: 29 · 2018: 27 · 2017: 14
- FWCI
- 12.06
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Genes & Diseases (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK105118)
- Cancer Center, University of Illinois at Chicago
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Keywords
- gut microbiota, colorectal cancer, inflammation, tumor progression, chronic infection, bacterial virulence factors, host-microbe interactions, intestinal barrier function, cancer prevention, cancer diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review